Winship treats first lung cancer patient with T-cell receptor

Cancers, Free Full-Text

PDF) Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study

Winship Weekly Winship Cancer Institute

How Science Became Hope 50th Anniversary of the National Cancer Act

IJMS, Free Full-Text

Winship Roundup

GAINING GROUND ON LUNG CANCER

Biomedicines, Free Full-Text

How Science Became Hope 50th Anniversary of the National Cancer Act

Winship treats first lung cancer patient with T-cell receptor therapy

Tumor Treating Fields Plus SOC May Benefit OS in Metastatic NSCLC

Winship Magazine - Spring 2022 by EmoryWeb - Issuu

PDF) Emerging therapies for small cell lung cancer